Assuntos
Glucocorticoides/efeitos adversos , Hanseníase Dimorfa/diagnóstico , Hanseníase Virchowiana/diagnóstico , Mycobacterium leprae/isolamento & purificação , Pele/efeitos dos fármacos , Administração Cutânea , Adulto , Infecções Assintomáticas , Biópsia , Diagnóstico Diferencial , Erros de Diagnóstico , Quimioterapia Combinada/métodos , Eczema/diagnóstico , Eczema/tratamento farmacológico , Glucocorticoides/administração & dosagem , Humanos , Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Dimorfa/imunologia , Hanseníase Dimorfa/microbiologia , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/microbiologia , Masculino , Pele/imunologia , Pele/microbiologia , Pele/patologia , Tinha/diagnóstico , Tinha/tratamento farmacológicoRESUMO
Erythema nodosum leprosum (ENL) is characterized by tender erythematous nodules, accompanied by fever, malaise, arthralgia, and systemic complications. Atypical clinical manifestations have been reported such as pustular, bullous, ulceration; livedo reticularis; erythema multiforme-like reaction; and Sweet's syndrome (SS)-like presentation. We reported a case of ENL reaction presenting as SS-like reaction in a borderline lepromatous leprosy patient.
Assuntos
Eritema Nodoso/diagnóstico , Hanseníase Dimorfa/diagnóstico , Hanseníase Virchowiana/diagnóstico , Síndrome de Sweet/diagnóstico , Adulto , Eritema Nodoso/microbiologia , Eritema Nodoso/patologia , Humanos , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Masculino , Mycobacterium leprae/genética , Mycobacterium leprae/isolamento & purificação , Síndrome de Sweet/microbiologia , Síndrome de Sweet/patologiaAssuntos
Hanseníase Dimorfa/diagnóstico , Mycobacterium leprae/isolamento & purificação , Doenças do Tecido Conjuntivo Indiferenciado/diagnóstico , Anticorpos Antibacterianos/análise , Diagnóstico Diferencial , Humanos , Hanseníase Dimorfa/microbiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae/imunologia , Doenças NegligenciadasRESUMO
Erythema Nodosum Leprosum (ENL) is an immune reaction in leprosy that aggravates the patient´s clinical condition. ENL presents systemic symptoms of an acute infectious syndrome with high leukocytosis and intense malaise clinically similar to sepsis. The treatment of ENL patients requires immunosuppression and thus needs to be early and efficient to prevent both disabilities and permanent nerve damage. Some patients experience multiple episodes of ENL and prolonged use of immunosuppressive drugs may lead to serious adverse effects. Thalidomide treatment is extremely effective at ameliorating ENL symptoms. Several mechanisms have been proposed to explain the efficacy of thalidomide in ENL, including the inhibition of TNF production. Given its teratogenicity, thalidomide is prohibitive for women of childbearing age. A rational search for molecular targets during ENL episodes is essential to better understand the disease mechanisms involved, which may also lead to the discovery of new drugs and diagnostic tests. Previous studies have demonstrated that IFN-γ and GM-CSF, involved in the induction of CD64 expression, increase during ENL. The aim of the present study was to investigate CD64 expression during ENL and whether thalidomide treatment modulated its expression. Leprosy patients were allocated to one of five groups: (1) Lepromatous leprosy, (2) Borderline leprosy, (3) Reversal reaction, (4) ENL, and (5) ENL 7 days after thalidomide treatment. The present study demonstrated that CD64 mRNA and protein were expressed in ENL lesions and that thalidomide treatment reduced CD64 expression and neutrophil infiltrates-a hallmark of ENL. We also showed that ENL blood neutrophils exclusively expressed CD64 on the cell surface and that thalidomide diminished overall expression. Patient classification based on clinical symptoms found that severe ENL presented high levels of neutrophil CD64. Collectively, these data revealed that ENL neutrophils express CD64, presumably contributing to the immunopathogenesis of the disease.
Assuntos
Eritema Nodoso/imunologia , Hansenostáticos/uso terapêutico , Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Receptores de IgG/genética , Talidomida/uso terapêutico , Adolescente , Adulto , Idoso , Biópsia , Eritema Nodoso/diagnóstico , Eritema Nodoso/tratamento farmacológico , Eritema Nodoso/microbiologia , Feminino , Humanos , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Dimorfa/imunologia , Hanseníase Dimorfa/microbiologia , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/microbiologia , Masculino , Pessoa de Meia-Idade , Receptores de IgG/imunologia , Pele/microbiologia , Pele/patologia , Adulto JovemAssuntos
Hanseníase Dimorfa/diagnóstico , Hanseníase Virchowiana/diagnóstico , Mycobacterium lepraemurium/isolamento & purificação , Pele/microbiologia , Adulto , Antibacterianos/uso terapêutico , Biópsia , Quimioterapia Combinada , Feminino , Glucocorticoides/uso terapêutico , Humanos , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Mycobacterium lepraemurium/efeitos dos fármacos , Valor Preditivo dos Testes , Pele/efeitos dos fármacos , Pele/patologia , Resultado do TratamentoRESUMO
Background: Mycobacterium leprae and HIV cause infectious diseases of great concern for the public health care sector worldwide. Both are especially worrisome diseases when patients become co-infected and exhibit the expected clinical exuberance. The objective of this study was to evaluate episodes of reversal reaction (RR) and the effect of the use of corticosteroids on the treatment of borderline tuberculoid leprosy patients co-infected with the human immunodeficiency virus (HIV). Methods: This is a retrospective cohort study in which the clinical manifestations of the patients and their responses to corticosteroid therapy were observed. Variables were analysed during and after multidrug therapy between the first and last days of prednisone, which occurred up to a maximum of 6 months after initiating corticosteroid therapy. Results: A total of 22 HIV-positive and 28 HIV-negative cases were included. Loss of sensitivity and neural thickening were statistically significant while clinically ulcerated lesions were only observed in the co-infected group. Most patients were diagnosed with leprosy in the presence of RR and six patients manifested RR as an immune reconstitution inflammatory syndrome. On average, both groups received similar doses of corticosteroids (difference of 0·1 mg/kg/day).
Assuntos
Corticosteroides/administração & dosagem , Coinfecção/tratamento farmacológico , Infecções por HIV/complicações , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Tuberculoide/tratamento farmacológico , Corticosteroides/efeitos adversos , Adulto , Coinfecção/microbiologia , Coinfecção/virologia , Feminino , Infecções por HIV/virologia , Humanos , Hanseníase Dimorfa/microbiologia , Hanseníase Tuberculoide/microbiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae/efeitos dos fármacos , Mycobacterium leprae/fisiologia , Estudos Retrospectivos , Adulto JovemRESUMO
Hansen Disease (leprosy) is an infectious disease that targets macrophages and Schwann cells, caused by the acid fast intracellular organism, Mycobacterium leprae. Clinically, it presents with a spectrum of findings that may include hypopigmented macules, erythematous plaques and nodules, and thickened or tender peripheral nerves. The most feared complication is mutilating damage to facial structures or digits resulting from loss of sensation in affected skin. In non-endemic areas, the diagnosis of leprosy is frequently delayed because it may mimic other more common skin conditions. We present a case of borderline/lepromatous leprosy in an otherwise healthy young Brazilian man that was initially diagnosed as tinea versicolor, but did not respond to appropriate treatment. This case highlights the importance of having a high index of suspicion for leprosy in patients from endemic areas who present with lesions that could be consistent with this disease.
Assuntos
Erros de Diagnóstico , Hanseníase Dimorfa/diagnóstico , Hanseníase Virchowiana/diagnóstico , Tinha Versicolor/diagnóstico , Clofazimina/administração & dosagem , Clofazimina/uso terapêutico , Contraindicações , Dapsona , Diagnóstico Tardio , Humanos , Hipestesia/etiologia , Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/complicações , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/complicações , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Masculino , Minociclina/administração & dosagem , Minociclina/uso terapêutico , Mycobacterium leprae/isolamento & purificação , Rifampina/administração & dosagem , Rifampina/uso terapêutico , Adulto JovemAssuntos
Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/patologia , Idoso , Clofazimina/uso terapêutico , Humanos , Hanseníase Dimorfa/diagnóstico , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Dimorfa/microbiologia , Hanseníase Virchowiana/diagnóstico , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/microbiologia , Masculino , Minociclina/uso terapêutico , Mycobacterium leprae/efeitos dos fármacos , Mycobacterium leprae/isolamento & purificação , Mycobacterium leprae/patogenicidade , Prednisona/uso terapêutico , Rifampina/uso terapêutico , Resultado do TratamentoRESUMO
Leprosy is a devastating disease caused by Mycobacterium leprae. It includes a spectrum of clinicopathological lesions. Neuritic leprosy with caseation necrosis (abscess) manifesting as a soft tissue mass is a relatively rare presentation of leprosy. Here, the authors report their experience with three patients with neuritic leprosy. The patients presented with swellings in the right ulnar nerve, the right great auricular nerve, and the temporal branch of the right sixth cranial nerve. The clinical impression was that of tumorous masses. Gross examination of the biopsy specimens revealed caseous necrotic materials. Further histological evaluation disclosed tuberculoid granulomas with extensive caseation necrosis. Stains for acid-fast bacilli were positive in the third case. A comparison between the caseation encountered in the tuberculoid neurotic leprosy and the neurolysis of lepromatous neurotic leprosy has been also discussed. The findings here emphasize "mass lesion with necrosis" as a possible clinical presentation of the neuritic leprosies. The clinicopathologic features were addressed and the relevant literature was reviewed.
Assuntos
Nervo Abducente/patologia , Abscesso/patologia , Hanseníase Dimorfa/patologia , Hanseníase Tuberculoide/patologia , Neurite (Inflamação)/patologia , Pele/patologia , Nervo Ulnar/patologia , Nervo Abducente/microbiologia , Abscesso/microbiologia , Adolescente , Biópsia , Feminino , Humanos , Hanseníase Dimorfa/microbiologia , Hanseníase Tuberculoide/microbiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae/isolamento & purificação , Necrose , Neurite (Inflamação)/microbiologia , Pele/microbiologia , Nervo Ulnar/microbiologiaRESUMO
Tumor necrosis factor α antagonists are proven to be effective for the treatment of chronic inflammatory conditions, such as psoriasis. A major concern for patients is the risk of acquiring granulomatous infectious diseases caused by the immunosuppressive effects of the drugs. We report a 60-year-old man with psoriasis who underwent infliximab treatment for 2 years and developed secondary leprosy, presenting extensive erythematous and infiltrated plaques on the trunk and limbs with loss of sensitivity (thermal, pain and tactile). The skin lesion biopsy showed perivascular epithelioid granulomas, nodular dermal aggregates of foamy macrophages and bundles of acid-fast bacilli. The clinical picture associated with histopathologic evaluation suggested borderline lepromatous leprosy. Before infliximab treatment, the patient had a positive tuberculin skin test and underwent chemoprophylaxis treatment for latent tuberculosis. Although the tuberculin reactivity suggests a strong correlation with a latent Mycobacterium tuberculosis infection, the possibility of infections by other mycobacteria, such as Mycobacterium leprae, should not be discarded.
Assuntos
Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais/uso terapêutico , Hanseníase Dimorfa/diagnóstico , Hanseníase Dimorfa/microbiologia , Psoríase/tratamento farmacológico , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Antituberculosos/uso terapêutico , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Infliximab , Tuberculose Latente/diagnóstico , Tuberculose Latente/tratamento farmacológico , Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae , Mycobacterium tuberculosis , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/microbiologiaRESUMO
Female aged 55 years presented with signs and symptoms of borderline lepromatous leprosy and presence of a non-healing ulcer and multiple haemorrhagic blisters over dorsum of both feet. Discharge from the various lesions was subjected to microbiological examination and an unusual organism Shewanella purtefaciens was isolated which was sensitive to most routine antibiotics. Patient responded well to cephadroxil therapy with uneventful and complete healing of ulcer and blisters.
Assuntos
Úlcera do Pé/complicações , Úlcera do Pé/microbiologia , Infecções por Bactérias Gram-Negativas/complicações , Hanseníase Dimorfa/complicações , Hanseníase Virchowiana/complicações , Shewanella putrefaciens/classificação , Antibacterianos/uso terapêutico , Vesícula/complicações , Vesícula/tratamento farmacológico , Vesícula/microbiologia , Cefadroxila/uso terapêutico , Feminino , Úlcera do Pé/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Pessoa de Meia-Idade , Shewanella putrefaciens/efeitos dos fármacos , Shewanella putrefaciens/isolamento & purificaçãoRESUMO
INTRODUCTION: Leprosy is a chronic disease caused by infection with Mycobacterium leprae, an obligate intracellular parasite. A problem in studying the transmission of leprosy is the small amount of variation in bacterial genomic DNA. The discovery of variable number of tandem repeats (VNTRs) allowed the detection of strain variation in areas with a high prevalence of leprosy. Four genotypes of M. leprae based on three single-nucleotide polymorphism (SNPs) were also discovered to be useful for analysis of the global spread of leprosy. METHODS: In this present study, we examined the allelic diversity of M. leprae at 16 select VNTR and three SNP loci using 89 clinical isolates obtained from patients mainly from the neighbouring states of São Paulo and Rio de Janeiro Brazil. RESULTS AND CONCLUSION: By use of a PCR-RFLP-based procedure that allows the recognition of SNP types 3 and 4 without the need for the more expensive DNA sequencing steps, characterisation of the main M. leprae genotypes was easy. When applied on the study population, it was found that the SNP type 3 is most frequent in these two states of Brazil, and that VNTRs provided further discrimination of the isolates. Two Short Tandem Repeats (STRs) were monomorphic, with the remaining 14 STRs represented by two to 18 alleles. Epidemiological associations with township or state were not evident in this random collection and require further investigations. In phylogenetic trees, branches formed by all 16 STRs clearly separated SNP type 3 organisms from the other types while the allelic patterns of two minisatellite loci 27-5 and 12-5 were highly correlated with SNP type 3. This strain typing study provide the basis for comparison of M. leprae strain types within Brazil and with those from other countries, and informed selection of genomic markers and methods for future studies.
Assuntos
Variação Genética , Hanseníase Dimorfa/microbiologia , Hanseníase Virchowiana/microbiologia , Mycobacterium leprae/genética , Brasil/epidemiologia , DNA Bacteriano/química , DNA Bacteriano/genética , Humanos , Hanseníase Dimorfa/epidemiologia , Hanseníase Virchowiana/epidemiologia , Repetições Minissatélites , Filogenia , Polimorfismo de Nucleotídeo ÚnicoRESUMO
Leprosy is rare in Australia, particularly in the southern states. We report two cases of leprosy in southern Australia that presented to the dermatology outpatients' department within a 4-month period. The presentation of the first case was complex, making the correct diagnosis difficult. Both cases involved immigrants from South-East Asia, were classified as multi-bacillary leprosy as defined by the World Health Organization, and were commenced on the recommended multiple drug therapy. The ensuing clinical course was complicated, with both cases developing Type 1 leprosy reactions. The first case also developed the rare but serious dapsone-induced delayed hypersensitivity reaction.
Assuntos
Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/diagnóstico , Hanseníase Dimorfa/tratamento farmacológico , Adulto , Idoso de 80 Anos ou mais , Braço/patologia , Dorso/patologia , Clofazimina/uso terapêutico , Dapsona/efeitos adversos , Dapsona/uso terapêutico , Diagnóstico Diferencial , Hipersensibilidade a Drogas/etiologia , Quimioterapia Combinada , Face/patologia , Feminino , Antebraço/patologia , Glucocorticoides/uso terapêutico , Humanos , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Masculino , Mycobacterium leprae/isolamento & purificação , Rifampina/uso terapêutico , Resultado do TratamentoRESUMO
A lepromatous patient treated with dapsone in the pre-MDT era to the point of smear negativity (> 6 years), relapsed 5 years after stopping treatment. He was then put on WHO-MDT for multibacillary (MB) leprosy, and was treated again; he had negative slit skin smears (3 years). He again presented with a relapse of leprosy 17 years after stopping treatment, and this time he presented with borderline leprosy in reaction.
Assuntos
Dapsona , Hansenostáticos , Hanseníase Dimorfa , Hanseníase Virchowiana , Mycobacterium leprae/efeitos dos fármacos , Dapsona/administração & dosagem , Dapsona/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Humanos , Hansenostáticos/administração & dosagem , Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/diagnóstico , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/prevenção & controle , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/prevenção & controle , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae/isolamento & purificação , Recidiva , Resultado do TratamentoRESUMO
Seven multibacillary leprosy and two suspected cases assisted in different situations during clinical care activities at the university in Rio de Janeiro city are described. All cases presented some difficulties for diagnosis, since they evolved with few or no cardinal signs or symptoms of leprosy. A serological test used as an auxiliary tool was helpful in the diagnosis or exclusion procedure of each case, facilitating academic discussions at the time of case examination. Considering serology and bacilloscopy (skin smear) as the only rapid and relatively cheap available tests for confirmation of atypical MB leprosy, the advantages and disadvantages of their use were discussed. Both tests support the diagnostic procedure and the classification of cases for treatment purposes. The advantage of bacilloscopy is its capacity for diagnosis confirmation. The advantages of serology are: (a) its applicability for direct use by health workers, providing immediate results; (b) the potential for patient participation in the process; and (c) it provides a learning opportunity, allowing for improved teaching of leprosy pathogenesis.
Assuntos
Anticorpos Antibacterianos/sangue , Antígenos de Bactérias , Glicolipídeos , Hanseníase Dimorfa/diagnóstico , Hanseníase Virchowiana/diagnóstico , Mycobacterium leprae/imunologia , Adulto , Idoso , Antígenos de Bactérias/imunologia , Criança , Diagnóstico Diferencial , Feminino , Glicolipídeos/imunologia , Humanos , Imunoglobulina M/sangue , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Pele/microbiologia , Pele/patologiaRESUMO
Sete casos de hanseníase multibacilar (MB) e dois casos com suspeição de hanseníase atendidos em situações distintas do atendimento clínico-dermatológico na Universidade Federal do Rio de Janeiro são descritos. Todos apresentaram dificuldades no diagnóstico visto que não tinham sinais e sintomas cardinais da hanseníase. Um teste sorológico utilizado como ferramenta auxiliar foi útil no processo de diagnóstico ou exclusão de cada caso e facilitou as discussões acadêmicas na hora do exame clínico. A sorologia e baciloscopia de linfa são consideradas como os únicos instrumentos rápidos e de baixo custo para a confirmação de casos MB atípicos, e as vantagens e desvantagens de cada exame são discutidas. Ambos os testes complementam o processo diagnóstico e classificação dos casos para fins terapêuticos. A vantagem da baciloscopia está na sua capacidade de confirmação do diagnóstico. As vantagens da sorologia são: (a) sua aplicabilidade para uso direto por profissionais de saúde no momento da consulta, visto que os resultados são imediatos, (b) a possibilidade da participação dos pacientes no processo, e (c) oferece uma oportunidade para melhor ensino da patogênese da hanseníase.
Seven multibacillary leprosy and two suspected cases assisted in different situations during clinical care activities at the university in Rio de Janeiro city are described. All cases presented some difficulties for diagnosis, since they evolved with few or no cardinal signs or symptoms of leprosy. A serological test used as an auxiliary tool was helpful in the diagnosis or exclusion procedure of each case, facilitating academic discussions at the time of case examination. Considering serology and bacilloscopy (skin smear) as the only rapid and relatively cheap available tests for confirmation of atypical MB leprosy, the advantages and disadvantages of their use were discussed. Both tests support the diagnostic procedure and the classification of cases for treatment purposes. The advantage of bacilloscopy is its capacity for diagnosis confirmation. The advantages of serology are: (a) its applicability for direct use by health workers, providing immediate results; (b) the potential for patient participation in the process; and (c) it provides a learning opportunity, allowing for improved teaching of leprosy pathogenesis.
Assuntos
Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Anticorpos Antibacterianos/sangue , Antígenos de Bactérias , Glicolipídeos , Hanseníase Dimorfa/diagnóstico , Hanseníase Virchowiana/diagnóstico , Mycobacterium leprae/imunologia , Antígenos de Bactérias/imunologia , Diagnóstico Diferencial , Glicolipídeos/imunologia , Imunoglobulina M/sangue , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Sensibilidade e Especificidade , Pele/microbiologia , Pele/patologiaRESUMO
Regulation of inflammation in leprosy may be influenced by local concentrations of active cortisol and inactive cortisone, whose concentrations are regulated by enzymes in the cortisol-cortisone shuttle. We investigated the cortisol-cortisone shuttle enzymes in the skin of leprosy patients with type 1 reactions (T1R), which are characterised by skin and nerve inflammation. Gene expression of the shuttle enzymes were quantified in skin biopsies from 15 leprosy patients with new T1R before and during prednisolone treatment and compared with levels in skin biopsies from 10 borderline leprosy patients without reactions. Gene expression of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 2, which converts cortisol to cortisone, is down-regulated in skin from T1R lesions. However expression levels of 11beta-HSD type 1, which converts cortisone to cortisol, were similar in skin with and without reactions and did not change during anti-leprosy drug treatment. Prednisolone treatment of patients with reactions is associated with an upregulation of 11beta-HSD2 expression in skin. The down regulation of 11beta-HSD2 at the beginning of a reaction may be caused by pro-inflammatory cytokines in the leprosy reactional lesion and may be a local attempt to down-regulate inflammation. However in leprosy reactions this local response is insufficient and exogenous steroids are required to control inflammation.
Assuntos
Cortisona/metabolismo , Hidrocortisona/metabolismo , 11-beta-Hidroxiesteroide Desidrogenase Tipo 1/biossíntese , 11-beta-Hidroxiesteroide Desidrogenase Tipo 1/genética , 11-beta-Hidroxiesteroide Desidrogenase Tipo 1/metabolismo , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/biossíntese , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/genética , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/metabolismo , Cortisona/imunologia , Expressão Gênica , Humanos , Hidrocortisona/imunologia , Índia , Hanseníase Dimorfa/genética , Hanseníase Dimorfa/imunologia , Hanseníase Dimorfa/metabolismo , Hanseníase Dimorfa/microbiologia , Prednisolona/imunologiaRESUMO
The effect of solid-organ transplantation on the acquisition, presentation and course of leprosy is unknown. We present a case of leprosy in a heart transplant recipient with multiple unique features possibly attributed to altered immune function.
Assuntos
Transplante de Coração/efeitos adversos , Hanseníase Dimorfa/etiologia , Hanseníase Virchowiana/etiologia , Idoso , Criptosporidiose/etiologia , Infecções por Citomegalovirus/etiologia , Rejeição de Enxerto/tratamento farmacológico , Humanos , Terapia de Imunossupressão/efeitos adversos , Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/imunologia , Hanseníase Dimorfa/microbiologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/microbiologia , Hanseníase Virchowiana/patologia , Masculino , Mycobacterium tuberculosis/isolamento & purificaçãoRESUMO
BACKGROUND: The diagnosis of tuberculoid leprosy is often difficult on hematoxylin and eosin (H&E) due to the absence of demonstrable nerve destruction. This study evaluates the utility of S-100 staining in identifying nerve fragmentation and differentiation of tuberculoid leprosy from other cutaneous granulomatous diseases. METHODS: Fifty cases of leprosy including 38 borderline tuberculoid (BT), two tuberculoid (TT), and 10 indeterminate leprosy (IL) were studied. Eleven controls of non-lepromatous cutaneous granulomatous lesions were included. S-100 was used for identifying the following dermal nerve patterns: infiltrated (A), fragmented (B), absent (C), and intact (D) nerves. RESULTS: On H&E, only 18/38 (47.4%) BT cases and 1/2 (50%) TT cases revealed neural inflammation. On S-100 staining of BT cases, 28/38 (73.7%) showed pattern B followed by patterns C and A in 8/38 (21.1%) and 2/38 (5.3%) cases, respectively. Both the TT cases showed pattern B. Only intact nerves (D) were seen in all the control cases. S-100 identified nerve damage in 4/10 (40%) IL cases. The patterns A, B, and C had sensitivity, specificity, and positive and negative predictive values of 100% in diagnosing tuberculoid (BT + TT) leprosy. CONCLUSIONS: S-100 is superior to H&E in identifying nerve fragmentation (p < 0.01). It also aids the differential diagnosis of tuberculoid leprosy.
Assuntos
Biomarcadores/metabolismo , Hanseníase Dimorfa/metabolismo , Hanseníase Tuberculoide/metabolismo , Nervos Periféricos/metabolismo , Proteínas S100/metabolismo , Pele/patologia , Biópsia , Células Epitelioides/metabolismo , Células Epitelioides/microbiologia , Células Epitelioides/patologia , Granuloma/microbiologia , Granuloma/patologia , Humanos , Técnicas Imunoenzimáticas , Hanseníase Dimorfa/diagnóstico , Hanseníase Dimorfa/microbiologia , Hanseníase Tuberculoide/diagnóstico , Hanseníase Tuberculoide/microbiologia , Mycobacterium leprae/isolamento & purificação , Nervos Periféricos/microbiologia , Nervos Periféricos/patologia , Estudos Prospectivos , Pele/inervação , Pele/microbiologia , Dermatopatias/metabolismo , Dermatopatias/microbiologia , Dermatopatias/patologiaRESUMO
Humanized monoclonal antibodies to tumor necrosis factor- alpha are valuable for the treatment of rheumatologic conditions, but they have been associated with the development of serious infections. We report the first 2 cases of leprosy developing after treatment with infliximab. After discontinuation of infliximab, both patients developed type 1 ("reversal") leprosy reactions.